International Multiple Sclerosis Genetics Consortium (IMSGC) United States of America (USA)
Research
Date range: 1 June 2023 - 31 May 2024
Research collaboration: International Multiple Sclerosis Genetics Consortium (IMSGC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Partner Institutions
International Multiple Sclerosis Genetics Consortium (IMSGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Brigham and Women's Hospital (BWH)
- Broad Institute of MIT and Harvard
- Cardiff University
- Catholic University of Leuven (KU Leuven)
- Charité - University Medicine Berlin
- Griffith University
- Harvard University
- Karolinska University Hospital
- Keele University
- Massachusetts Institute of Technology (MIT)
- National Institute for Health and Welfare (THL)
- Peninsula College of Medicine and Dentistry (PCMD)
- Queen's University Belfast (QUB)
- Rigshospitalet
- San Raffaele Scientific Institute
- Sorbonne University
- Technical University of Munich (TUM)
- The University of Melbourne (UniMelb)
- The University of Newcastle (UON)
- The University of Sydney (USYD)
- UiO Ullevål Hospital
- University Medical Center Mainz, JGU
- University of California, Berkeley (UC Berkeley)
- University of California, San Francisco (UCSF)
- University of Cambridge
- University of Copenhagen (UCPH)
- University of Eastern Piedmont "Amedeo Avogadro" (UNIPMN)
- University of Miami (UM)
- University of Montreal (UdeM)
- University of Oslo (UiO)
- University of Otago
- Vall d'Hebron University Hospital (HUVH), ICS
- Vanderbilt University Medical Center (VUMC)
- Wellcome Sanger Institute